Table 2 Comparisons of V-FABP4 and V-VEGFA in comorbidity.

From: Detection of significantly high vitreous concentrations of fatty acid-binding protein 4 in patients with proliferative diabetic retinopathy

 

non-PDR (n = 20)

PDR (n = 20)

(−)

(+)

P

(−)

(+)

P

Vitreous hemorrhage

n

20

0

 

9

11

 

V-FABP4 (ng/mg protein)

0.30 (0.26–0.35)

–

− 1.76 (0.69–3.50)

0.99 (0.60–2.29)

0.939

 

V-VEGFA (pg/mg/protein)

7.4 (5.9–8.4)

–

− 95.1 (32.0–302.1)

179.4 (82.6–287.1)

0.518

 

Diabetes mellitus

n

16

4

 

0

20

 

V-FABP4 (ng/mg protein)

0.30 (0.26–0.34)

0.34 (0.27–0.61)

0.422

–

1.14 (0.65–3.03)

–

V-VEGFA (pg/mg protein)

7.4 (6.0–8.4)

7.1 (5.4–12.6)

0.850

–

166.4 (50.3–295.1)

–

Hypertension

n

12

8

 

12

8

 

V-FABP4 (ng/mg protein)

0.28 (0.25–0.31)

0.34 (0.30–0.63)

0.019

0.91 (0.60–3.37)

1.57 (0.91–3.00)

0.418

V-VEGFA (pg/mg/protein)

7.9 (5.9–9.9)

6.5 (5.7–8.4)

0.589

88.9 (35.8–291.5)

233.3 (126.1–303.2)

0.263

  1. Variables are expressed as number or medians (interquartile ranges).
  2. PDR proliferative diabetic retinopathy; V-FABP4 fatty acid-binding protein 4 in vitreous humor; V-VEGFA vascular endothelial growth factor A in vitreous humor.
Back to article page